During the past decade, Alfieri Cardiology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 11 clinical trials were completed, i.e. on average, 157.1% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alfieri Cardiology" #1 sponsor was "Lantheus Medical Imaging" with 4 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "Point Biomedical" with 3 trials sponsored, "Pfizer" with 2 trials sponsored and "American Regent, Inc." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alfieri Cardiology" #1 collaborator was "Duke Clinical Research Institute" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Syneos Health" with 2 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Alfieri Cardiology" are "Coronary Artery Disease" (5 trials), "Cardiovascular Disease" (4 trials), "Cardiac Disease" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Alfieri Cardiology" in a lesser frequency.

Most popular intervention types in "Alfieri Cardiology" are "Drug" (18 trials), "Procedure" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Apixaban" (2 trials), "DEFINITY®" (2 trials), "PB127 for Injectable Suspension" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Alfieri Cardiology" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Alfieri Cardiology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Alfieri Cardiology, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Alfieri Cardiology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".